A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.
Clinical trial NCT07520565 · RECRUITING
Trial details
- NCT number
- NCT07520565
- Sponsor
- Biocells (Beijing) Biotech Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2027-07-01
- Enrollment
- 1112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.